Utility of immunoinformatics in epitope mapping for vaccine and therapeutic design
DOI:
https://doi.org/10.56294/evk2025152Keywords:
Immunoinformatics, Vaccines, Epitopes, Antigens, Computational Biology, Vaccine DevelopmentAbstract
Epitope identification is largely the basis for the development of new vaccine candidates and immunotherapies. However, traditional methods for epitope identification present certain limitations in terms of time and high costs, hence experimentation in this field is targeted and rationalized. The development of omics, as well as the introduction of bioinformatics techniques and tools in biomedical specialties, has allowed the development of immunoinformatics, which has the capacity to speed up the discovery process. The present communication aims to describe the potential of immunoinformatics in epitope mapping for the design of vaccines and therapies.
References
1. Keen MM, Keith AD, Ortlund EA. Epitope mapping via in vitro deep mutational scanning methods and its applications. Journal of Biological Chemistry [Internet]. enero de 2025 [citado 27 de mayo de 2025];301(1):108072. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0021925824025742 DOI: https://doi.org/10.1016/j.jbc.2024.108072
2. Patronov A, Doytchinova I. T-cell epitope vaccine design by immunoinformatics. Open Biol [Internet]. enero de 2013 [citado 27 de mayo de 2025];3(1):120139. Disponible en: https://royalsocietypublishing.org/doi/10.1098/rsob.120139 DOI: https://doi.org/10.1098/rsob.120139
3. Habib A, Liang Y, Xu X, Zhu N, Xie J. Immunoinformatic Identification of Multiple Epitopes of gp120 Protein of HIV-1 to Enhance the Immune Response against HIV-1 Infection. IJMS [Internet]. 19 de febrero de 2024 [citado 27 de mayo de 2025];25(4):2432. Disponible en: https://www.mdpi.com/1422-0067/25/4/2432 DOI: https://doi.org/10.3390/ijms25042432
4. Zafar S, Bai Y, Muhammad SA, Guo J, Khurram H, Zafar S, et al. Molecular dynamics simulation based prediction of T-cell epitopes for the production of effector molecules for liver cancer immunotherapy. Sehgal SA, editor. PLoS ONE [Internet]. 3 de enero de 2025 [citado 27 de mayo de 2025];20(1):e0309049. Disponible en: https://dx.plos.org/10.1371/journal.pone.0309049 DOI: https://doi.org/10.1371/journal.pone.0309049
5. Rosario-Cruz R, Domínguez-García DI, López-Silva S, Rosario-Domínguez F. Immunoinformatics and tick vaccinology. Explor Immunol [Internet]. 24 de febrero de 2023 [citado 27 de mayo de 2025];1-16. Disponible en: https://www.explorationpub.com/Journals/ei/Article/100385 DOI: https://doi.org/10.37349/ei.2023.00085
6. Ansari H, Raghava GP. Identification of conformational B-cell Epitopes in an antigen from its primary sequence. Immunome Res [Internet]. 2010 [citado 27 de mayo de 2025];6(1):6. Disponible en: http://www.immunome-research.com/content/6/1/6 DOI: https://doi.org/10.1186/1745-7580-6-6
7. Moise L, Gutiérrez AH, Khan S, Tan S, Ardito M, Martin WD, et al. New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand. Front Immunol [Internet]. 5 de octubre de 2020 [citado 27 de mayo de 2025];11:563362. Disponible en: https://www.frontiersin.org/article/10.3389/fimmu.2020.563362/full DOI: https://doi.org/10.3389/fimmu.2020.563362
8. I AA, G VRT, Aguilar-S Á, T ÁHS. Promesas y limitaciones de las vacunas génicas. Revista Mexicana de Ciencias Farmacéuticas [Internet]. 2006 [citado 27 de mayo de 2025];37(2):26-37. Disponible en: https://www.redalyc.org/articulo.oa?id=57937205
9. Tong JC, Ren EC. Immunoinformatics: Current trends and future directions. Drug Discov Today [Internet]. julio de 2009 [citado 27 de mayo de 2025];14(13):684-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108239/ DOI: https://doi.org/10.1016/j.drudis.2009.04.001
10. Prawiningrum AF, Paramita RI, Panigoro SS. Immunoinformatics Approach for Epitope-Based Vaccine Design: Key Steps for Breast Cancer Vaccine. Diagnostics (Basel). 28 de noviembre de 2022;12(12):2981. DOI: https://doi.org/10.3390/diagnostics12122981
11. Bock C, Datlinger P, Chardon F, Coelho MA, Dong MB, Lawson KA, et al. High-content CRISPR screening. Nat Rev Methods Primers [Internet]. 10 de febrero de 2022 [citado 27 de mayo de 2025];2(1):8. Disponible en: https://www.nature.com/articles/s43586-021-00093-4 DOI: https://doi.org/10.1038/s43586-021-00093-4
12. De Dios Hernández D. In silico exploration of potential breast cancer drugs. Interamerican Journal of Health Sciences [Internet]. 1 de abril de 2024 [citado 27 de mayo de 2025];4:171. Disponible en: https://ijhsc.uai.edu.ar/index.php/ijhsc/article/view/47 DOI: https://doi.org/10.59471/ijhsc2024171
13. Immune Epitope Database and Analysis Resource (IEDB) | NIAID: National Institute of Allergy and Infectious Diseases [Internet]. 2024 [citado 27 de mayo de 2025]. Disponible en: https://www.niaid.nih.gov/research/immune-epitope-database
14. Satam H, Joshi K, Mangrolia U, Waghoo S, Zaidi G, Rawool S, et al. Next-Generation Sequencing Technology: Current Trends and Advancements. Biology (Basel). 13 de julio de 2023;12(7):997. DOI: https://doi.org/10.3390/biology12070997
Published
Issue
Section
License
Copyright (c) 2025 Carlos Alfredo Miló Valdés, Lidia Cecilia Pérez Acevedo, Adrián Alejandro Vitón Castillo (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
